Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04496687 · ClinicalTrials.gov registry record

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

A clinical trial of Spontaneous Coronary Artery Dissection, sponsored by SCAD Alliance.

Recruiting
Registry status
1,000
Enrollment target
20
Study locations

NCT04496687 is a study of Spontaneous Coronary Artery Dissection that is actively recruiting participants, run by SCAD Alliance. The registered enrollment target is 1,000 participants, above the 688-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (45% higher). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04496687, a study of Spontaneous Coronary Artery Dissection, is actively recruiting participants, sponsored by SCAD Alliance.

RECRUITING
Registry status
1,000 participants
Enrollment target
20
Study locations

Study Summary

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD. The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.

Conditions Studied

Spontaneous Coronary Artery Dissection

Study Locations (20)

California

  • Cedars Sinai - Los Angeles
  • UCLA (University of California, Los Angeles) - Los Angeles
  • Kaiser Permanente Northern California - San Francisco

Missouri

  • St. Luke's Mid America - Kansas City
  • Washington University - St Louis

New Hampshire

  • Dartmouth-Hitchcock - Lebanon
  • Catholic Medical Center - Manchester

New York

  • Mount Sinai - New York
  • Columbia University Medical Center - New York

Colorado

  • University of Colorado - Aurora

Connecticut

  • Hartford Hospital - Hartford

Florida

  • University of South Florida - Tampa

Georgia

  • Emory Healthcare System - Atlanta

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2019-03-08
Est. Completion 2025-12-31

Sponsor

SCAD Alliance

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04496687

The ClinicalTrials.gov registry entry for NCT04496687 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 688-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (45% higher). The listed sponsor is SCAD Alliance, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spontaneous Coronary Artery Dissection appearing as the primary indexed condition, and to 0 interventions.

NCT04496687 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Missouri, New Hampshire.

Frequently Asked Questions

What is clinical trial NCT04496687 about?

NCT04496687 is a clinical study titled "International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry". The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and ther...

What is the current status of trial NCT04496687?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-03-08. Estimated completion is 2025-12-31.

What conditions does trial NCT04496687 study?

This clinical trial studies the following conditions: Spontaneous Coronary Artery Dissection.

Who is sponsoring clinical trial NCT04496687?

This trial is sponsored by SCAD Alliance, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04496687 being conducted?

This trial has 20 study locations across California, Colorado, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spontaneous Coronary Artery Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Spontaneous Coronary Artery Dissection

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.